An examination of drug-drug interactions with raltegravir.
Edmunds-Ogbuokiri
Justina
J
D003376:Counseling; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011760:Pyrrolidinones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D014481:United States; D014486:United States Food and Drug Administration
D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium